Accuracy of Detecting Residual Disease After Cross Neoadjuvant Chemoradiotherapy for Esophageal Cancer (preSANO Trial): Rationale and Protocol.
Bo Jan NoordmanJoel ShapiroManon C W SpaanderKausilia K KrishnadathHanneke Wilma Marlies van LaarhovenMark Ivo van Berge HenegouwenGrard A P NieuwenhuijzenRichard van HillegersbergMeindert N SosefEwout Willem SteyerbergBas P L WijnhovenJ Jan B van Lanschotnull nullPublished in: JMIR research protocols (2015)
Netherlands Trial Register: NTR4834; http://www.trialregister.nl/trialreg/admin/rctview.asp?TC=4834 (archived by Webcite at http://www.webcitation.org/6Ze7mn67B).